Clinical Trials Directory

Trials / Completed

CompletedNCT00159588

Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly? A Randomized Multi-centre Follow-up.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

It is a common belief that patients with MOH rarely respond of preventative medications whilst overusing acute medications. However, no randomized trial has been done previously to prove such statement. Based on some clinical experiences, our hypothesis are patients with probably MOH may benefit from use of preventive medications better than treatment with abrupt withdrawal or no specific treatment.

Detailed description

This randomized multi-centre study started January 2004, and patients with probably MOH have been included from five different University hospitals in Norway. The last patient was included November 9th 2006, final inclusion date was December 31th 2006. At this time a total of 64 patients with probable MOH according to the International Classification of Headache Disorders, 2nd Edition (2004) were included. The included patients were randomized to one out of three possible options: 1. Abrupt withdrawal of the acute medication(s) they have been overusing. After 3 month: use of preventative medication (best choice)in those who need such treatment, 12 month follow-up. 2. Start with preventative medication (best choice) directly without abrupt withdrawal, 12 month follow-up. 3. No specific treatment (controls), 5 month follow-up.

Conditions

Interventions

TypeNameDescription
DRUGBetablockers or other preventive drugs based on primary headache typeSeveral preventive drugs based on each individual regarding type of original headache type (i.e angiotensin II blockers, betablockers, valproate, tricyclic antidepressants or gabapentin)

Timeline

Start date
2004-01-01
Primary completion
2006-11-01
Completion
2007-12-01
First posted
2005-09-12
Last updated
2022-03-11
Results posted
2021-12-01

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00159588. Inclusion in this directory is not an endorsement.